Question to the Department of Health and Social Care:

To ask His Majesty's Government what plans they have to engage with external stakeholders in the development of a cost-benefit analysis of the centralised procurement and supply of adult flu vaccines, in line with paragraph 4.5.6 of the NHS Vaccination Strategy.

The NHS Vaccination Strategy outlined the intention to explore whether centralising the procurement and supply of adult flu vaccines could deliver better outcomes and address the existing clinical, operational, and financial challenges associated with local procurement. NHS England, the Department, and the UK Health Security Agency are working in partnership on a programme of work to consider this. This will include undertaking a cost-benefit analysis and market engagement with stakeholders. The work, including timelines, is still under development and subject to ministerial decision-making.